Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,381 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00005053 | Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 35 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Sep 24, 2012 | clinicaltrials |
| NCT00014300 | Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme | completed | Phase 2 | 32 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 |
| Sep 24, 2012 |
| clinicaltrials |
| NCT01009593 | Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) | terminated | Phase 3 | 1,035 | AbbottINDUSTRY | 29 | Sep 10, 2012 | clinicaltrials |
| NCT00707304 | Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer(FORTIS-M) | completed | Phase 3 | 742 | AgennixINDUSTRY | 23 | Aug 21, 2012 | clinicaltrials |
| NCT00005980 | Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 116 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 18, 2012 | clinicaltrials |
| NCT00002903 | Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer | completed | Phase 2 | 25 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Jul 2, 2012 | clinicaltrials |
| NCT00002904 | Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors | completed | Phase 1 | 40 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Jul 2, 2012 | clinicaltrials |
| NCT00003028 | MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 5 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Jul 2, 2012 | clinicaltrials |
| NCT00003287 | Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | completed | Phase 3 | 554 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 2, 2012 | clinicaltrials |
| NCT00003730 | Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer | completed | N/A | 80 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Jul 2, 2012 | clinicaltrials |
| NCT00257205 | CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy | completed | Phase 3 | 655 | AstraZenecaINDUSTRY | 21 | Jul 2, 2012 | clinicaltrials |
| NCT00754351 | Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast Cancer | completed | Phase 2 | 48 | University Hospital of CreteOTHER | 1 | Jun 28, 2012 | clinicaltrials |
| NCT00442026 | Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLC | terminated | Phase 3 | 106 | Hellenic Oncology Research GroupOTHER | 1 | Jun 27, 2012 | clinicaltrials |
| NCT00435409 | A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer | completed | Phase 3 | 442 | PfizerINDUSTRY | 18 | Jun 26, 2012 | clinicaltrials |
| NCT00312845 | Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma | completed | Phase 3 | 676 | Millennium Pharmaceuticals, Inc.INDUSTRY | 32 | Jun 25, 2012 | clinicaltrials |
| NCT01524445 | Retrospective Survey of Re-treatment With Bortezomib | completed | — | 35 | Janssen Pharmaceutica N.V., BelgiumINDUSTRY | 1 | Jun 12, 2012 | clinicaltrials |
| NCT00003215 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma | completed | Phase 3 | 400 | Swiss Cancer InstituteOTHER | 5 | May 15, 2012 | clinicaltrials |
| NCT00453635 | Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients | terminated | Phase 2 | 88 | Hellenic Oncology Research GroupOTHER | 1 | Mar 13, 2012 | clinicaltrials |
| NCT01399086 | Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer | completed | — | 140 | Hellenic Oncology Research GroupOTHER | 1 | Mar 13, 2012 | clinicaltrials |
| NCT00094029 | A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248 | approved for marketing | — | — | PfizerINDUSTRY | 34 | Mar 9, 2012 | clinicaltrials |
| NCT00130897 | Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma | approved for marketing | — | — | PfizerINDUSTRY | 50 | Mar 9, 2012 | clinicaltrials |
| NCT00003589 | Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 3 | 450 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Mar 6, 2012 | clinicaltrials |
| NCT01470586 | Surgical Resection Lowers Oxidative Stress Markers in Patients With Colorectal Cancer | completed | N/A | 60 | G. Hatzikosta General HospitalOTHER | 1 | Nov 11, 2011 | clinicaltrials |
| NCT00926107 | Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only Relapse | terminated | Phase 2 | 9 | Hellenic Cooperative Oncology GroupOTHER | 1 | Nov 10, 2011 | clinicaltrials |
| NCT01212549 | Comparison of Two Schemes of Cryosurgery and Imiquimod Combination Treatment for Basal Cell Carcinoma(IMCXvsCIMT) | completed | Phase 3 | 14 | University of IoanninaOTHER | 1 | Sep 2, 2011 | clinicaltrials |
| NCT01212562 | Treatment of Primary Basal Cell Carcinomas of the Skin With Combination of Topical Imiquimod and Cryosurgery(IMCX) | completed | — | 70 | University of IoanninaOTHER | 1 | Sep 2, 2011 | clinicaltrials |
| NCT00302016 | Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia | no longer available | — | — | Novartis PharmaceuticalsINDUSTRY | 34 | Aug 26, 2011 | clinicaltrials |
| NCT00691990 | Classic Total Thyroidectomy With or Without Drains | completed | N/A | 100 | Aristotle University Of ThessalonikiOTHER | 1 | Aug 4, 2011 | clinicaltrials |
| NCT00429559 | Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma | completed | Phase 1 / Phase 2 | 31 | Hellenic Oncology Research GroupOTHER | 1 | Jul 22, 2011 | clinicaltrials |
| NCT00429247 | Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients | completed | Phase 2 | 75 | University Hospital of CreteOTHER | 1 | Jul 21, 2011 | clinicaltrials |
| NCT01392781 | Markers and Calculation of Cardiovascular Risk in the Distinct Phenotypes of Polycystic Ovary Syndrome | unknown | — | 300 | Aristotle University Of ThessalonikiOTHER | 1 | Jul 13, 2011 | clinicaltrials |
| NCT00614965 | Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV | completed | Phase 2 | 124 | Hellenic Oncology Research GroupOTHER | 1 | May 23, 2011 | clinicaltrials |
| NCT00750386 | Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas | completed | Phase 1 / Phase 2 | 50 | Hellenic Oncology Research GroupOTHER | 1 | May 23, 2011 | clinicaltrials |
| NCT00790894 | Trial of Ixabepilone in Patients With HER-2 Negative Metastatic Breast Cancer (HIT)(HIT) | terminated | Phase 2 | 64 | Hellenic Cooperative Oncology GroupOTHER | 1 | May 18, 2011 | clinicaltrials |
| NCT01301248 | Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck | unknown | Phase 2 | 80 | Theagenio Cancer HospitalOTHER_GOV | 1 | May 17, 2011 | clinicaltrials |
| NCT00688740 | Docetaxel in Node Positive Adjuvant Breast Cancer(TAX316) | completed | Phase 3 | 1,491 | SanofiINDUSTRY | 20 | Feb 16, 2011 | clinicaltrials |
| NCT00206219 | Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX) | completed | Phase 3 | 477 | AstraZenecaINDUSTRY | 25 | Jan 27, 2011 | clinicaltrials |
| NCT00082277 | Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer(SABRE) | completed | Phase 4 | 237 | AstraZenecaINDUSTRY | 8 | Jan 26, 2011 | clinicaltrials |
| NCT00401323 | Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | completed | Phase 2 / Phase 3 | 568 | SanofiINDUSTRY | 20 | Jan 20, 2011 | clinicaltrials |
| NCT01135732 | Cytological Evaluation of Biliary Epithelium After Endoscopic Sphincterotomy | completed | — | 56 | University of AthensOTHER | 1 | Nov 16, 2010 | clinicaltrials |
| NCT00895674 | Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With Nexavar | completed | — | 2,840 | BayerINDUSTRY | 18 | Sep 30, 2010 | clinicaltrials |
| NCT00440414 | Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 320 | Hellenic Oncology Research GroupOTHER | 1 | Aug 19, 2010 | clinicaltrials |
| NCT00469443 | Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC | completed | Phase 3 | 330 | Hellenic Oncology Research GroupOTHER | 1 | Aug 19, 2010 | clinicaltrials |
| NCT00705315 | Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast Cancer | completed | Phase 1 / Phase 2 | 46 | Hellenic Oncology Research GroupOTHER | 1 | Aug 19, 2010 | clinicaltrials |
| NCT00831909 | Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLIN(EPICLIN) | completed | — | 3,513 | AstraZenecaINDUSTRY | 8 | Aug 10, 2010 | clinicaltrials |
| NCT00783471 | Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC)(DOPERLO) | terminated | Phase 2 | 51 | Hellenic Cooperative Oncology GroupOTHER | 1 | Jun 16, 2010 | clinicaltrials |
| NCT01024504 | Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 46 | Hellenic Oncology Research GroupOTHER | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00371566 | A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer | completed | Phase 2 | 107 | GlaxoSmithKlineINDUSTRY | 5 | Apr 6, 2010 | clinicaltrials |
| NCT00101608 | Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium | completed | Phase 2 | 150 | Bristol-Myers SquibbINDUSTRY | 15 | Mar 2, 2010 | clinicaltrials |
| NCT01070732 | Paracetamol as Antipyretic and Analgesic Medication(APOTEL01) | completed | Phase 4 | 100 | University of AthensOTHER | 1 | Feb 18, 2010 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials